Trial Profile
A retrospective study evaluating efficacy and safety of Cladribine in Turkish patients with hairy cell leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2016
Price :
$35
*
At a glance
- Drugs Cladribine (Primary)
- Indications Hairy cell leukaemia
- Focus Therapeutic Use
- 22 Jul 2016 New trial record